These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1720054)

  • 1. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
    Tropé C; Kaern J; Vergote I
    Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing perspectives on intraperitoneal chemotherapy.
    Hoff ST
    J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
    Gao SY; Han JH; Li HY
    Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy.
    Markman M
    Semin Oncol; 1991 Jun; 18(3):248-54. PubMed ID: 2042064
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraperitoneal therapy in the management of patients with ovarian cancer.
    McClay EF; Howell SB
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
    Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
    Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
    [No Abstract]   [Full Text] [Related]  

  • 9. The port: delivering intraperitoneal chemotherapy in ovarian cancer.
    Doane LS
    Todays OR Nurse; 1992 Sep; 14(9):11-8. PubMed ID: 1412628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Second line chemotherapy of carcinoma of the ovary. Current approaches].
    Sesti F; Mantenuto L; Ciancaglini G; Zupi E; Terenzi S; Piccione E
    G Ital Oncol; 1989; 9(4):121-4. PubMed ID: 2693348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal chemotherapy for ovarian carcinoma.
    Markman M
    Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functioning of implantable catheters of intraperitoneal chemotherapy].
    de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications associated with intraperitoneal chemotherapy catheters.
    Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
    Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal chemotherapy for ovarian cancer.
    de Castro G; Snitcovsky IM; Federico MH
    N Engl J Med; 2006 Apr; 354(15):1641-3; author reply 1641-3. PubMed ID: 16615184
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
    Marth C; Walker JL; Barakat RR; Casado A; Gadducci A; Miller B; Odicino F; Pujade-Lauraine E; Sehouli J; Tropé C; Wenzel L; Zeimet AG
    Cancer; 2007 Feb; 109(4):645-9. PubMed ID: 17238177
    [No Abstract]   [Full Text] [Related]  

  • 17. How to give peritoneal chemotherapy.
    Doane LS; Fischer LM; McDonald TW
    Am J Nurs; 1990 Apr; 90(4):58-64. PubMed ID: 2321681
    [No Abstract]   [Full Text] [Related]  

  • 18. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
    Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.
    Meunier F; van der Auwera P; Aoun M; Piccart M; Sculier JP
    Scand J Infect Dis Suppl; 1990; 72():26-8. PubMed ID: 2151063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer".
    Markman M
    Gynecol Oncol; 2010 May; 117(2):390; author reply 391. PubMed ID: 20149423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.